参考文献/References:
[1] Zhou W,Liesz A,Bauer H,et al.Postischemic brain infiltration of leukocyte subpopulations differs among murine permanent and transient focal cerebral ischemia models[J].Brain Pathol,2013,23(1):34-44.
[2] Chu HX,Kim HA,Lee S,et al.Immune cell infiltration in malignant middle cerebral artery infarction: comparison with transient cerebral ischemia[J].J Cereb Blood Flow Metab,2014,34(3):450-459.
[3] Liesz A,Suri-Payer E,Veltkamp C,et al.Regulatory T cells are key cerebroprotective immunomodulators in acute experimental stroke[J].Nat Med,2009,15(2):192-199.
[4] Stubbe T,Ebner F,Richter D,et al.Regulatory T cells accumulate and proliferate in the ischemic hemisphere for up to 30 days after MCAO[J].J Cereb Blood Flow Metab,2013,33(1):37-47.
[5] Sakaguchi S,Sakaguchi N,Asano M,et al.Pillars article: immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor α-chains(CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 1995[J].J Immunol,2011,186(7):3808-3821.
[6] Gelderblom M,Leypoldt F,Steinbach K,et al.Temporal and spatial dynamics of cerebral immune cell accumulation in stroke[J].Stroke,2009,40(5):1849-1857.
[7] Llovera G,Hofmann K,Roth S,et al.Results of a preclinical randomized controlled multicenter trial(pRCT): Anti-CD49d treatment for acute brain ischemia[J].Sci Transl Med,2015,7(299):299ra121.
[8] Liesz A,Zhou W,Na SY,et al.Boosting regulatory T cells limits neuroinflammation in permanent cortical stroke[J].J Neurosci,2013,33(44):17350-17362.
[9] Kleinschnitz C,Kraft P,Dreykluft A,et al.Regulatory T cells are strong promoters of acute ischemic stroke in mice by inducing dysfunction of the cerebral microvasculature[J].Blood,2013,121(4):679-691.
[10] Liesz A,Hu X,Kleinschnitz C,et al.Functional role of regulatory lymphocytes in stroke: facts and controversies[J].Stroke,2015,46(5):1422-1430.
[11] Xie L,Sun F,Wang J,et al.mTOR signaling inhibition modulates macrophage/microglia-mediated neuroinflammation and secondary injury via regulatory T cells after focal ischemia[J].J Immunol,2014,192(12):6009-6019.
[12] Liesz A,Hagmann S,Zschoche C,et al.The spectrum of systemic immune alterations after murine focal ischemia: immunodepression versus immunomodulation[J].Stroke,2009,40(8):2849-2858.
[13] Li P,Mao L,Zhou G,et al.Adoptive regulatory T-cell therapy preserves systemic immune homeostasis after cerebral ischemia[J].Stroke,2013,44(12):3509-3515.
[14] Sakaguchi S,Miyara M,Costantino CM.FOXP3(+)regulatory T cells in the human immune system[J].Nat Rev Immunol,2010,10(7):490-500.
[15] Bodhankar S,Chen Y,Vandenbark AA,et al.IL-10-producing B-cells limit CNS inflammation and infarct volume in experimental stroke[J].Metab Brain Dis,2013,28(3):375-386.
[16] Wang,J.Activated regulatory T cell regulates neural stem cell proliferation in the subventricular zone of normal and ischemic mouse brain through interleukin 10[Z],2015:361.
[17] Bodhankar S,Chen Y,Lapato A,et al.PD-L1 monoclonal antibody treats ischemic stroke by controlling central nervous system inflammation[J].Stroke,2015,46(10):2926-2934.
[18] Li P,Gan Y,Sun BL,et al.Adoptive regulatory T-cell therapy protects against cerebral ischemia[J].Ann Neurol,2013,74(3):458-471.
[19] Langhauser,F.Blocking of alpha4 integrin does not protect from acute ischemic stroke in mice[J].Stroke,2014,45(6):1799-1806.
[20] Wang SZ,Y.Xu,crosstalk between microglia and T cells contributes to brain damage and recovery after ischemic stroke[J].Neurol Res,2016,38(6):495-503.
[21] Li Q,Wang Y,Yu F,et al.Peripheral Th17/Treg imbalance in patients with atherosclerotic cerebral infarction[J].Int J Clin Exp Pathol,2013,6(6):1015-1027.
[22] Yan J,Greer JM,Etherington K,et al.Immune activation in the peripheral blood of patients with acute ischemic stroke[J].J Neuroimmunol,2009,206(1/2):112-117.
[23] Li P,Mao L,Liu X,et al.Essential role of program death 1-ligand 1 in regulatory T-cell-afforded protection against blood-brain barrier damage after stroke[J].Stroke,2014,45(3):857-864.
[24] Na SY,Mracsko E,Liesz A,et al.Amplification of regulatory T cells using a CD28 superagonist reduces brain damage after ischemic stroke in mice[J].Stroke,2015,46(1):212-220.